HealthFortuneabout 3 hours ago
AstraZeneca said to have explored Bristol Myers merger
2 min read
AstraZeneca Plc explored acquiring Bristol Myers Squibb Co. in early-stage talks that could create one of the world's largest drugmakers. Bristol Myers, valued at $133 billion, faces patent losses on Eliquis and Opdivo, which make up half its sales.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
